| 1 | GILD | Gilead Sciences, Inc. | 6.29% |
| 2 | BIIB | Biogen Inc. | 5.74% |
| 3 | AMGN | Amgen Inc. | 5.69% |
| 4 | REGN | Regeneron Pharmaceuticals, Inc. | 5.35% |
| 5 | UTHR | United Therapeutics Corporation | 5.18% |
| 6 | INCY | Incyte Corporation | 4.93% |
| 7 | ILMN | Illumina, Inc. | 4.72% |
| 8 | FOLD | Amicus Therapeutics, Inc. | 4.11% |
| 9 | ALNY | Alnylam Pharmaceuticals, Inc. | 3.69% |
| 10 | RPRX | Royalty Pharma plc | 3.19% |
| 11 | MNKD | MannKind Corporation | 3.11% |
| 12 | BMRN | BioMarin Pharmaceutical Inc. | 3.06% |
| 13 | QGEN | Qiagen N.V. | 3.06% |
| 14 | IONS | Ionis Pharmaceuticals, Inc. | 2.95% |
| 15 | HALO | Halozyme Therapeutics, Inc. | 2.95% |
| 16 | EXEL | Exelixis, Inc. | 2.86% |
| 17 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.84% |
| 18 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.82% |
| 19 | COLL | Collegium Pharmaceutical, Inc. | 2.81% |
| 20 | TECH | Bio-Techne Corporation | 2.66% |
| 21 | PTGX | Protagonist Therapeutics, Inc. | 2.65% |
| 22 | ACAD | ACADIA Pharmaceuticals Inc. | 2.56% |
| 23 | TGTX | TG Therapeutics, Inc. | 2.51% |
| 24 | PTCT | PTC Therapeutics, Inc. | 2.51% |
| 25 | VCEL | Vericel Corporation | 2.48% |
| View PBE holdings |
